Rosenön Meeting 2009: DMPK Aspects of Drug Combinations

Rosenön Meeting 2009: DMPK Aspects of Drug Combinations http://www.lakemedelsakademin.se/templates/kurs/kurstillfalle.aspx?kId=3458&id=3457 September 17-19, 2009 Stockholm, Sweden This year's meeting will deal with various aspects of drug combinations both from a preclinical and clinical point of view. We will discuss methods to identify and predict clinical relevant drug-drug interactions. We will also look into PK/PD aspects of drug combinations as well as pharmacogenetic implications for certain patient groups. In addition we will debate regulatory aspects of drug combinations. Speakers Michel Eichelbaum, Dr. Margarete Fischer-Bosch - IKP, Kim Brouwer, University of North Carolina, Heyo Kroemer, Ernst Moritz Arndt University of Greifswald, Magnus Ingelman-Sundberg, Karolinska Institutet, Johan Gabrielsson, AstraZeneca R&D Mölndal, Kuresh Youdim, Pfizer Global R&D, Sandwich, Thomas Bouillon, Novartis Pharma, Ulf Diczfalusy, Karolinska University Hospital, Mikko Niemi, University of Helsinki, Ylva Böttiger, Karolinska University Hospital, Erik Eliasson, Karolinska University Hospital, Filip Josephson, Karolinska University Hospital, Qun-Ying Yue, The Medical Products Agency, Monica Edholm, The Medical Products Agency, Gustav Ahlin, Uppsala University, Urban Fagerholm, AstraZeneca R&D Södertälje More speakers will be announced soon! Please visit www.swepharm.se/Rosenon2009 to see the preliminary program Welcome! Erik Ahlzén, Project Manager The Swedish Academy of Pharmaceutical Sciences [email protected]